A new report shows while cancer death rates among Black people are declining, they remain higher than other racial and ethnic ...

Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are contributing to up to half of patients are not getting the right treatment for ...

Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...

Black individuals had a 2-fold risk of cancer death related to prostate, myeloma, and stomach cancers compared with White ...

For patients with metastatic castration-resistant prostate cancer (mCRPC) unselected for homologous recombination repair (HRR ...

Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero ...

The National Cancer Audit Collaborating Centre said prostate, kidney and colon cancers were the worst affected with ...

The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.

Traditional therapies targeting ... Study Finds New Blood Test Predicts Prognosis for Advanced Prostate Cancer Patients Dec. 11, 2024 — A new study found that a DNA sequencing test for advanced ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...